High Roller Technologies announced a commercial agreement with ProphetX to integrate ProphetX’s sports-focused prediction markets into the ROLR platform. This integration will allow eligible ROLR users to trade additional sports event contracts through a ROLR-branded interface, expanding market options and creating new revenue streams through a revenue-sharing model. The partnership leverages ProphetX’s regulated exchange infrastructure, while ROLR manages branding and customer acquisition. The integration depends on regulatory approvals and is expected to launch after ROLR FCM LLC obtains futures commission merchant registration, with no set date yet.
High Roller Technologies is the subject, here is Pluang's Technology sector snapshot as of Nov 12, 2026 20:21 WIB: Out of 150 US tech stocks, 25 rose and 121 fell. HubSpot Inc (HUBS) gained 8.41% to USD 219.94 with full buy orders. Nvidia Corp (NVDA) dropped 8.25% to USD 159.40, with 69% buy orders. Expensify Inc (EXFY) fell 7.87% to USD 1.64, with all sell orders.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
